|Generic Name||Brand Name|
Pemetrexed interferes with the cancer cell's ability to reproduce. Pemetrexed is an intravenous (IV) medication that is usually given in a dose based on body surface area. The type and extent of a cancer determines the exact dose and schedule of administering this drug.
Pemetrexed slows or stops the growth and spread of cancer cells in the body. It is used to treat non–small cell lung cancer that has spread (metastasized) outside the lung.
Pemetrexed is an effective antitumor medication. However, the type and extent of a cancer determines how effectively this medication slows or stops the growth of cancer cells in the body.
Side effects are rare, but possible serious side effects of pemetrexed include:
Less serious side effects are more common and may include:
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Pemetrexed should be administered only under the supervision of a medical oncologist.
Pemetrexed can affect your ability to have children. You may not be able to get pregnant or father a child after taking this medication. Discuss fertility with your doctor before starting treatment.
Pemetrexed can cause birth defects. Do not use this medication if you are pregnant or wish to become pregnant or to father a child while you are taking it.
Your doctor can prescribe medicines to help you manage any nausea or vomiting caused by chemotherapy.
Nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin or ibuprofen, are often stopped for 2 days before and during treatment with pemetrexed, to avoid kidney problems.
Other Works Consulted
- Pemetrexed (Alimta) for mesothelioma (2004). Medical Letter on Drugs and Therpeutics, 46(1180): 31–32.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.